Shandong Weigao repurchases H shares, boosts treasury holdings

Shandong Weigao Group Medical Polymer Company Limited announced on September 3, 2025, that it repurchased 812,400 H shares on the Exchange. The shares were bought at prices ranging from HK$5.7 to HK$5.75 per share, with an aggregate price paid of HK$4,645,024. These repurchased shares will be held as treasury shares, increasing the total treasury share count to 12,838,000.

Following the repurchase, the number of issued shares (excluding treasury shares) decreased by 812,400 to 4,509,494,324, representing a 0.01801% change from the previous day's closing balance. The total number of issued shares remains 4,522,332,324.

The company's repurchase mandate, granted on May 27, 2025, authorized the repurchase of up to 451,560,392 shares. With this latest transaction, the cumulative number of shares repurchased under the mandate is 6,189,600, which accounts for 1.3707% of the issued shares (excluding treasury shares) as of the mandate date. A moratorium period for new share issues or treasury share sales is in effect until October 3, 2025.